Velan (VLN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
16 Nov, 2025Executive summary
Sales grew 18.6% year-over-year to $72.2 million, led by strong performance in Italy, China, India, and Germany, and robust MRO activity.
Gross profit margin improved by 100 basis points to 28.6%.
Cash position reached $59.1 million, the highest in five years, following major asset sales and liability settlements.
Quarterly dividend increased to CA$0.10 per share, reflecting confidence in future performance.
Net income from continuing operations was $17.8 million, compared to a net loss of $2.2 million last year, with consolidated net income totaling $77.2 million due to one-time gains.
Financial highlights
Gross profit rose to $20.6 million (28.6% margin) from $16.8 million (27.6%) year-over-year.
Adjusted EBITDA was $4.0 million, up from $2.8 million last year, excluding restructuring costs.
Adjusted net income from continuing operations was $0.1 million, with adjustments for restructuring and non-recurring items.
Backlog grew 4.1% to $286.1 million, with $241.3 million (84.4%) deliverable within 12 months.
Bookings for the quarter were $78.2 million, down from $83.0 million last year; book-to-bill ratio at 1.08.
Outlook and guidance
Strong backlog and cash flow support long-term growth objectives and shareholder returns.
Continued optimism for growth in China, the Middle East, and MRO activities, with new joint ventures and production orders in Saudi Arabia.
Bullish outlook on the nuclear sector, expecting further agreements and a longer-term revenue recognition cycle.
84.4% of backlog expected to be delivered in the next 12 months.
Management anticipates another solid performance in fiscal 2026 despite tariff uncertainties.
Latest events from Velan
- Bookings and backlog improved, supporting growth and cash flow focus for 2025.VLN
AGM 20243 Feb 2026 - Q1 sales up 14.5%, gross margin 30.7%, backlog $528.3M, and major nuclear deal signed.VLN
Q1 20253 Feb 2026 - Bookings and sales soared, backlog reached $548.1M, and net income turned positive.VLN
Q2 202519 Jan 2026 - Strong backlog, major asset sale, and ownership transition marked Q3 2026.VLN
Q3 202615 Jan 2026 - Q3 saw 18.1% sales growth, margin gains, and risk reduction from major divestitures.VLN
Q3 202510 Jan 2026 - Shareholders approved the $201.1 million sale of French subsidiaries to Framatome.VLN
EGM 202526 Dec 2025 - Sales and margins surged, with divestitures and a special dividend boosting future prospects.VLN
Q4 202524 Nov 2025 - Strong growth, risk reduction, and strategic expansion defined the year, with all motions approved.VLN
AGM 202516 Nov 2025 - Q2 sales fell 13%, but backlog and liquidity rose, supporting growth in key sectors.VLN
Q2 202612 Oct 2025